Literature DB >> 16123332

Loss of pentameric symmetry in C-reactive protein induces interleukin-8 secretion through peroxynitrite signaling in human neutrophils.

Tarek Khreiss1, Levente József, Lawrence A Potempa, János G Filep.   

Abstract

Plasma levels of C-reactive protein (CRP), nitrotyrosine, and interleukin-8 (IL-8) are known predictors of acute cardiovascular events. Peroxynitrite (ONOO-) may function as an intracellular signal for the production of IL-8; however, it is not known whether CRP regulates these events. Emerging evidence suggests that some bioactivities of CRP are expressed only when the pentameric structure of CRP is lost, resulting in formation of monomeric or modified CRP (mCRP). We studied the impact of human native CRP and bioengineered mCRP that cannot rearrange into the pentameric structure on ONOO- formation and ONOO--mediated IL-8 gene expression in human leukocytes. Incubation of human whole blood or isolated neutrophils with mCRP (0.1 to 100 microg/mL) for 4 hours increased IL-8 gene expression and secretion that was blocked approximately 70% by the NO synthase inhibitor Nomega-nitro-L-arginine methyl ester (L-NAME). In neutrophils, mCRP simultaneously increased superoxide production and endothelial nitric oxide synthase-mediated NO formation, leading to enhanced ONOO- formation, and consequently activation of nuclear factor-kappaB and activator protein-1. Native CRP had no detectable effect at 4 hours, whereas it enhanced IL-8 release after a 24-hour incubation that was blocked by L-NAME. An anti-CD16 antibody, but not an anti-CD32 antibody, produced 60% to 70% reductions in mCRP-stimulated NO formation and IL-8 release (both P<0.05). These results suggest that loss of the pentameric symmetry in CRP, resulting in formation of mCRP, leads to IL-8 release from human neutrophils via peroxynitrite-mediated activation of nuclear factor-kappaB and activator protein-1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16123332     DOI: 10.1161/01.RES.0000183881.11739.CB

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  43 in total

Review 1.  What are the most useful and trustworthy noninvasive anatomic markers of existing vascular disease?

Authors:  Benjamin J W Chow; John P Veinot
Journal:  Curr Cardiol Rep       Date:  2006-11       Impact factor: 2.931

2.  Monomeric C-reactive protein and inflammatory injury in myocardial infarction.

Authors:  Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2012-08-07       Impact factor: 10.787

3.  The combination of CRP isoforms with oxLDL decreases TNF-α and IL-6 release by U937-derived macrophages.

Authors:  Imtissal Krayem; Samer Bazzi; Marc Karam
Journal:  Biomed Rep       Date:  2017-07-21

4.  Topological localization of monomeric C-reactive protein determines proinflammatory endothelial cell responses.

Authors:  Hai-Yun Li; Jing Wang; Yue-Xin Wu; Lin Zhang; Zu-Pei Liu; János G Filep; Lawrence A Potempa; Yi Wu; Shang-Rong Ji
Journal:  J Biol Chem       Date:  2014-04-07       Impact factor: 5.157

5.  CRP enhances soluble LOX-1 release from macrophages by activating TNF-α converting enzyme.

Authors:  Xue Qiang Zhao; Ming Wei Zhang; Fei Wang; Yu Xia Zhao; Jing Jing Li; Xu Ping Wang; Pei Li Bu; Jian Min Yang; Xiao Ling Liu; Ming Xiang Zhang; Fei Gao; Cheng Zhang; Yun Zhang
Journal:  J Lipid Res       Date:  2011-03-01       Impact factor: 5.922

Review 6.  Disordered haematopoiesis and athero-thrombosis.

Authors:  Andrew J Murphy; Alan R Tall
Journal:  Eur Heart J       Date:  2016-02-10       Impact factor: 29.983

7.  C-reactive protein stimulates myeloperoxidase release from polymorphonuclear cells and monocytes: implications for acute coronary syndromes.

Authors:  Uma Singh; Sridevi Devaraj; Ishwarlal Jialal
Journal:  Clin Chem       Date:  2008-12-12       Impact factor: 8.327

8.  In vitro effects of azide-containing human CRP isoforms and oxLDL on U937-derived macrophage production of atherosclerosis-related cytokines.

Authors:  Dania Jundi; Imtissal Krayem; Samer Bazzi; Marc Karam
Journal:  Exp Ther Med       Date:  2020-09-04       Impact factor: 2.447

Review 9.  The evolving role of C-reactive protein in atherothrombosis.

Authors:  Sridevi Devaraj; Uma Singh; Ishwarlal Jialal
Journal:  Clin Chem       Date:  2008-12-18       Impact factor: 8.327

Review 10.  CRP and the risk of atherosclerotic events.

Authors:  Paolo Calabrò; Enrica Golia; Edward T H Yeh
Journal:  Semin Immunopathol       Date:  2009-05-05       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.